Prime Capital Investment Advisors LLC Invests $2.04 Million in OrthoPediatrics Corp. (NASDAQ:KIDS)

Prime Capital Investment Advisors LLC bought a new stake in OrthoPediatrics Corp. (NASDAQ:KIDS - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 62,610 shares of the company's stock, valued at approximately $2,035,000. Prime Capital Investment Advisors LLC owned approximately 0.27% of OrthoPediatrics as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Brown Capital Management LLC boosted its holdings in OrthoPediatrics by 6.4% in the second quarter. Brown Capital Management LLC now owns 3,507,638 shares of the company's stock valued at $153,810,000 after acquiring an additional 212,431 shares during the last quarter. BlackRock Inc. boosted its holdings in OrthoPediatrics by 6.6% in the second quarter. BlackRock Inc. now owns 1,097,013 shares of the company's stock valued at $48,104,000 after acquiring an additional 68,115 shares during the last quarter. Braidwell LP boosted its holdings in OrthoPediatrics by 39.0% during the third quarter. Braidwell LP now owns 1,057,770 shares of the company's stock worth $33,849,000 after buying an additional 296,562 shares during the last quarter. Vanguard Group Inc. boosted its holdings in OrthoPediatrics by 1.3% during the third quarter. Vanguard Group Inc. now owns 860,804 shares of the company's stock worth $27,546,000 after buying an additional 10,861 shares during the last quarter. Finally, New York State Common Retirement Fund boosted its holdings in OrthoPediatrics by 1.4% during the third quarter. New York State Common Retirement Fund now owns 557,462 shares of the company's stock worth $17,839,000 after buying an additional 7,429 shares during the last quarter. 69.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, insider Joseph W. Hauser sold 2,903 shares of OrthoPediatrics stock in a transaction that occurred on Thursday, February 22nd. The stock was sold at an average price of $28.06, for a total value of $81,458.18. Following the sale, the insider now owns 52,858 shares of the company's stock, valued at approximately $1,483,195.48. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, insider Joseph W. Hauser sold 2,903 shares of OrthoPediatrics stock in a transaction that occurred on Thursday, February 22nd. The stock was sold at an average price of $28.06, for a total value of $81,458.18. Following the sale, the insider now owns 52,858 shares of the company's stock, valued at approximately $1,483,195.48. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Mark C. Throdahl sold 2,433 shares of OrthoPediatrics stock in a transaction that occurred on Monday, March 11th. The shares were sold at an average price of $27.59, for a total value of $67,126.47. Following the completion of the sale, the director now directly owns 137,857 shares in the company, valued at approximately $3,803,474.63. The disclosure for this sale can be found here. Insiders have sold 17,253 shares of company stock worth $477,375 in the last 90 days. Corporate insiders own 32.60% of the company's stock.

Analyst Ratings Changes

A number of brokerages have issued reports on KIDS. JMP Securities restated a "market outperform" rating and set a $50.00 target price on shares of OrthoPediatrics in a report on Thursday, March 7th. Truist Financial cut OrthoPediatrics from a "buy" rating to a "hold" rating and reduced their target price for the stock from $39.00 to $31.00 in a report on Thursday, January 25th.

OrthoPediatrics Stock Up 1.5 %

Shares of NASDAQ:KIDS traded up $0.41 during trading on Monday, hitting $27.88. 107,599 shares of the company's stock traded hands, compared to its average volume of 177,867. OrthoPediatrics Corp. has a 52 week low of $23.10 and a 52 week high of $53.50. The company has a current ratio of 5.44, a quick ratio of 2.90 and a debt-to-equity ratio of 0.03. The company has a market cap of $656.57 million, a price-to-earnings ratio of -30.30 and a beta of 1.16. The company has a 50-day moving average price of $27.54 and a 200-day moving average price of $28.72.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last released its quarterly earnings data on Wednesday, March 6th. The company reported ($0.23) earnings per share for the quarter, beating the consensus estimate of ($0.28) by $0.05. OrthoPediatrics had a negative return on equity of 5.03% and a negative net margin of 14.10%. The business had revenue of $37.61 million for the quarter, compared to analysts' expectations of $37.59 million. As a group, research analysts forecast that OrthoPediatrics Corp. will post -1.34 EPS for the current fiscal year.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.